Business context and reporting period
Silicon Laboratories Inc. is a fabless semiconductor company focused on mixed-signal integrated circuits and wireless solutions for IoT applications, grouped into Industrial & Commercial and Home & Life. This filing reports the quarter ended September 30, 2023 and nine months ended September 30, 2023, compared with periods ended October 1, 2022. The request metadata says “2022 Q3,” but the filing itself is for 2023 Q3.
Financial results and liquidity
Amounts below are in millions of dollars, except per-share data and percentages.
| Metric | Q3 2023 | Q3 2022 | Nine months 2023 | Nine months 2022 |
|---|---|---|---|---|
| Revenue | $203.8 | $269.8 | $695.4 | $766.8 |
| Gross profit / margin | $119.0 / 58.4% | $165.6 / 61.4% | $416.7 / 59.9% | $485.3 / 63.3% |
| Operating income | $12.2 | $30.2 | $49.0 | $95.2 |
| Net income | $10.3 | $21.0 | $35.3 | $66.0 |
| Diluted EPS | $0.32 | $0.60 | $1.07 | $1.79 |
| Operating cash flow | Not provided by quarter | Not provided by quarter | $(48.9) | $127.4 |
- Q3 revenue fell 24.5% year over year; operating income declined about 60% and net income about 51%. Gross margin contracted 3.0 percentage points.
- Q3 revenue declines affected both product groups: Industrial & Commercial fell 17.0% to $121.0 million and Home & Life fell 33.3% to $82.8 million. For the nine months, Industrial & Commercial grew 4.9%, while Home & Life declined 26.2%.
- Nine-month operating cash flow was negative $48.9 million, versus positive $127.4 million a year earlier. Management attributed the current-period cash outflow largely to working-capital movements, including increases in receivables and inventory.
- At September 30, cash and cash equivalents were $159.9 million and short-term investments were $257.2 million, totaling $417.1 million, versus $1.192 billion at December 31, 2022. Accounts receivable were $102.1 million; inventory was $167.6 million.
- The $535 million principal amount of 0.625% convertible notes was settled or redeemed in June 2023 for cash and shares; no notes remained outstanding at quarter-end. The revolving credit facility had $45.0 million outstanding against $400 million of capacity. The company reported compliance with its covenants.
Material changes and management commentary
Management said customers were slowing purchases to reduce inventories amid a softening market and macroeconomic pressures, including inflation, higher interest rates and geopolitical tension. Customers increasingly requested order cancellations or delivery changes and sought price or payment concessions. The company extended payment terms for some Q3 sales and, to a lesser extent, offered price discounts. DSO rose to 45 days from 25 at year-end 2022; inventory days rose to 178 from 90.
Gross margin fell primarily because of product price and cost variation, product mix and lower unit volumes. Operating expenses declined year over year in Q3, partly from temporary cost controls—including reduced bonuses and variable compensation, fewer contract employees and suspended non-essential travel—and a reversal of stock-based compensation expense tied to lower expected performance-unit achievement. Management expected R&D and SG&A each to increase in absolute dollars in Q4.
Outlook, risks and unusual items
- Q4 fiscal 2023 outlook: revenue of $70–$100 million, gross margin of 53%, operating expenses of $123 million and diluted loss per share of $2.39–$1.95.
- The company expects approximately $6.5 million of restructuring expense in Q4, primarily severance from a reduction in force.
- Liquidity risks include continued weak demand, customer destocking, longer collection times and potential further payment-term concessions. Management believed available cash, investments, credit and expected operating cash generation were sufficient for short- and long-term needs, while noting additional funding could be sought or elected.
- Key operating risks include dependence on third-party foundries and assembly/test providers, particularly in Asia; semiconductor-cycle and inventory volatility; pricing pressure; and geopolitical risks affecting China, Taiwan and regional supply chains.
- The company is appealing a Norwegian tax assessment related to 2013 of approximately 141.3 million Norwegian kroner ($13.2 million). It believes its position is more likely than not to be sustained, but an unfavorable outcome could materially affect the financial statements. Other ordinary-course litigation was not expected to have a material adverse effect.
- Management reported disclosure controls were effective as of September 30, 2023 and no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Confirm the intended reporting year: the supplied metadata says 2022 Q3, whereas the filed 10-Q covers Q3 2023.
- Track Q4 revenue and margin against the unusually wide revenue outlook and 53% gross-margin estimate, given customer destocking and the projected quarterly loss.
- Monitor receivable collections, extended payment terms and elevated inventory for further working-capital pressure or potential inventory adjustments.
- Review cash and investment levels alongside debt repayment, the $45 million revolver balance and any future repurchases; the share-repurchase authorization had approximately $100 million remaining at quarter-end.
- Assess the outcome of the Norwegian tax appeal and the expected Q4 restructuring charges.